Monohydrochloride - dione 1 - 2.5 - 3 - (1 - methyl - 1H indole - 3 - yl) - 4 - [1 - (2 - pyridin - ylmethyl) piperidin-4-yl il] - 1H indole - 3 - yl] - 1H pyrrole Crystalline hydrate thereof or mixtures the mismos.2.Monohydrochloride - dione - 2.5 - 3 - (1 - methyl - 1H indole - 3 - yl) - 4 - [1 - (2 - pyridin - ylmethyl) piperidin-4-yl il] - 1H indole - 3 - yl] - 1H pyrrole Crystalline hydrate thereof, or mixtures of the same, that is a model of x-ray diffraction Peaks that includes the following: 6.8 + 10.9 + 0.1, 0.1, 0.1 and 14.2 + 16.6 + 0,1 in 2? When the model is derived from a Radiation source of copper (Cuka;? Three. - a) = 154056 monohydrochloride Crystal claims that a model of x-ray diffraction Peaks, which also includes the following: 6.3 7.2 + + 0.1, 0.1, 0.1 and 0,1u00b0 17.0 + 12.5 + 2? 4.A Pharmaceutical composition comprising a Salt of any of claims 1 - 3 and a vehicle farmacu00e9utico.5. - A method of treatment of lymphomas are non Hodgkin's - which comprises administering to a Mammal in need an effective amount of a composed Or to any one of claims 1 - 3.
展开▼
